Company
Circle Pharma
South San Francisco biotech founded in 2013. Develops oral macrocyclic drugs for cancer, led by a cyclin D1–Rb inhibitor.
1 story
Regulatory News has published 1 story about Circle Pharma on 21 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 21 September 2026.
This page is generated from Regulatory News’ editorial coverage of Circle Pharma. It is not an advertisement.
On the record
- Company
- Circle Pharma, Inc.
- Headquarters
- South San Francisco, California
- Founded
- 2013; David J. Earp has served as President and CEO since October 2013
- Regulator
- U.S. Food and Drug Administration (CID-165 is in IND-enabling development; no clearance or designation yet)
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
